|
⚲
|
| Keyboard |
| Robert Weisskoff | |
|---|---|
| Firm | |
| Address | c/o Affinia Therapeutics Inc 43 Foundry Ave, Suite 120 Waltham, MA 02453 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Affinia Therapeutics Inc | 021-560739 | Director | 13.3 M of 45.0 M |
||
| Adela Inc | 021-550950 | Director | 25.4 M of 27.0 M |
||
| Zenflow Inc | 021-529812 | Director | 19.4 M of 25.2 M |
||
| Adela Inc | 021-505327 | Director | 1.2 M of 1.2 M |
||
| Adela Inc | 021-505329 | Director | 3.3 M of 3.3 M |
||
| Adela Inc | 021-489534 | Director | 48.5 M of 49.3 M |
||
| Rarecyte Inc | 021-487794 | Director | 13.2 M of 35.7 M |
||
| Shouti Inc | 021-428629 | Director | 7.0 M of 7.0 M |
||
| Basecamp Bio Inc | 021-417877 | Director | 9.0 M of 14.0 M |
||
| Shouti Inc | 021-417848 | Director | 26.0 M of 26.0 M |
||
| Shouti Inc | 021-417860 | Director | 100.0 M of 100.0 M |
||
| Shouti Inc | 021-417842 | Director | 32.0 M of 32.0 M |
||
| Rarecyte Inc | 021-412919 | Director | 24.0 M of 24.0 M |
||
| Affinia Therapeutics Inc | 021-398517 | Director | 110.0 M of 110.0 M |
||
| Zenflow Inc | 021-396049 | Director | 24.4 M of 24.4 M |
||
| Caribou Biosciences Inc | 021-391380 | Director | 115.0 M of 115.0 M |
||
| Xilio Therapeutics Inc | 021-387002 | Director | 50.2 M of 50.2 M |
||
| Checkmate Pharmaceuticals Inc | 021-369265 | Director | 85.1 M of 100.1 M |
||
| Checkmate Pharmaceuticals Inc | 021-365710 | Director | 10.0 M of 10.0 M |
||
| Affinia Therapeutics Inc | 021-363863 | Director | 38.5 M of 68.5 M |
||
| Checkmate Pharmaceuticals Inc | 021-347004 | Director | 16.0 M of 16.0 M |
||
| Farapulse Inc | 021-319020 | Director | 12.0 M of 12.0 M |
||
| Tempest Therapeutics Inc | 021-306741 | Director | 83.2 M of 100.2 M |
||
| Zenflow Inc | 021-296213 | Director | 31.5 M of 32.2 M |
||
| Iowa Approach Inc | 021-290358 | Director | 5.0 M of 5.0 M |
||
| Caribou Biosciences Inc | 021-263801 | Director | 14.5 M of 30.1 M |
||
| Iowa Approach Inc | 021-258524 | Director | 15.0 M of 24.0 M |
||
| ViewRay Inc | 021-235161 | Director | 15.0 M of 15.0 M |
||
| ViewRay Inc | 021-231795 | Director | 16.3 M of 16.8 M |
||
| Caribou Biosciences Inc | 021-225136 | Director | 11.5 M of 11.5 M |
||
| ViewRay Inc | 021-207317 | Director | 15.0 M of 15.0 M |
||
| Bioconnect Systems Inc | 021-203529 | Director | 9.1 M of 12.5 M |
||
| Amphora Medical Inc | 021-197489 | Director | 12.8 M of 12.8 M |
||
| ViewRay Inc | 021-196697 | Director | 15.0 M of 17.4 M |
||
| ViewRay Inc | 021-188257 | Director | 10.9 M of 12.2 M |
||
| Bioconnect Systems Inc | 021-187890 | Director | 1.5 M of 1.6 M |
||
| ViewRay Inc | 021-174983 | Director | 26.3 M of 26.3 M |
||
| Bioconnect Systems Inc | 021-171774 | Director | 0.5 M of 0.9 M |
||
| ViewRay Inc | 021-161755 | Director | 10.3 M of 10.3 M |
||
| Transave Inc | 021-148242 | Director | 2.0 M of 6.0 M |
||
| ViewRay Inc | 021-145470 | Director | 20.0 M of 20.0 M |
||
| Accuri Cytometers Inc | 021-144654 | Director | 6.0 M of 6.0 M |
||
| Transave Inc | 021-144039 | Director | 5.5 M of 5.9 M |
||
| Acorn Cardiovascular Inc | 021-143220 | Director | 0.5 M of 0.5 M |
||
| Tetraphase Pharmaceuticals Inc | 021-142724 | Director | 44.8 M of 45.0 M |
||
| Ikano Therapeutics Inc | 021-101585 | Director | 0.9 M | ||
| Transave Inc | 021-50801 | Director | 5.5 M of 12.0 M |
||
| Tetraphase Pharmaceuticals Inc | 021-94056 | Director | 10.0 M of 29.6 M |
||
| Accuri Cytometers Inc | 021-102715 | Director | 3.7 M of 4.0 M |
||